Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
Spyros Chalkias, Charles Harper, Keith Vrbicky, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 14, pp. 1279-1291
Open Access | Times Cited: 571
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 210
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
Nature Immunology (2024) Vol. 25, Iss. 2, pp. 218-225
Open Access | Times Cited: 136
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 880-886.e4
Open Access | Times Cited: 105
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
Annika Rössler, Ludwig Knabl, Dorotheé von Laer, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1764-1766
Open Access | Times Cited: 88
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
Modified SEIAR infectious disease model for Omicron variants spread dynamics
Feng Cao, Xing Lü, Yi-Xuan Zhou, et al.
Nonlinear Dynamics (2023) Vol. 111, Iss. 15, pp. 14597-14620
Closed Access | Times Cited: 40
Fibrin drives thromboinflammation and neuropathology in COVID-19
Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montaño, et al.
Nature (2024) Vol. 633, Iss. 8031, pp. 905-913
Open Access | Times Cited: 21
SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
Rahul Suryawanshi, Melanie Ott
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 591-592
Open Access | Times Cited: 63
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
Cai He, H. J. Yang, Weiqi Hong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 48
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
I‐Jung Lee, Cheng‐Pu Sun, Ping‐Yi Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 40
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
Yuri Furusawa, Maki Kiso, Shun Iida, et al.
EBioMedicine (2023) Vol. 91, pp. 104561-104561
Open Access | Times Cited: 34
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting
Fajun Li, Junping Hong, Chaoheng Guan, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3383-3393
Closed Access | Times Cited: 26
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Noah Kojima, Katherine Adams, Wesley H. Self, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 547-557
Open Access | Times Cited: 26
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, et al.
mBio (2023)
Open Access | Times Cited: 25
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Xiantao Zhang, Shijian Wu, Jie Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 25
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A. Ellis, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
Astrid Korning Hvidt, Eva Anna Marianne Baerends, Ole S. Søgaard, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise
Karin Yaniv, Eden Ozer, Marilou Shagan, et al.
The Science of The Total Environment (2022) Vol. 836, pp. 155599-155599
Open Access | Times Cited: 27
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Qiugang Zhu, Yan Xu, Ting Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top